medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2014, Número 6

<< Anterior Siguiente >>

Ann Hepatol 2014; 13 (6)


Hepatitis C virus infection in patients and family members attending two primary care clinics in Puebla, Mexico

López-Colombo A, Meléndez-Mena D, Sedeño-Monge V, Camacho-Hernández JR, Vázquez-Cruz E, Morales-Hernández ER, Sosa-Jurado F, Márquez-Domínguez L, Santos-López G

Idioma: Ingles.
Referencias bibliográficas: 26
Paginas: 746-752
Archivo PDF: 97.66 Kb.


RESUMEN

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57: 1333-42.

  2. Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 2006; 3: 47-52.

  3. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clinical Microbiology and Infection 2011; 17: 107-15.

  4. Chevaliez S, Pawlotsky JM. Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease. Int J Med Sci 2006; 3: 35-40.

  5. Sosa-Jurado F, Santos-Lopez G, Guzman-Flores B, Ruiz-Conde JI, Melendez-Mena D, Vargas-Maldonado MT, Martinez- Laguna Y, et al. Hepatitis C virus infection in blood donors from the state of Puebla, Mexico. Virol J 2010; 7: 18.

  6. Alvarado-Mora MV, Pinho JR. Epidemiological update of hepatitis B, C and delta in Latin America. Antivir Ther 2013; 18: 429-33.

  7. Fundación Mexicana para la Salud Hepática. La hepatitis C como un problema de salud pública en México. Sal Pub Mex 2011; 53: S61-S67.

  8. Valdespino JL, Conde-González CJ, Olaiz-Fernández G, Palma O, Kershenobich D, Sepúlveda J. Seroprevalencia de la hepatitis C en adultos de México: ¿ un problema de salud pública emergente. Sal Pub Mex 2007; 49: s395-s403.

  9. Santos-Lopez G, Sosa-Jurado F, Vallejo-Ruiz V, Melendez- Mena D, Reyes-Leyva J. Prevalence of hepatitis C virus in the Mexican population: a systematic review. J Infection 2008; 56: 281-90.

  10. Chiquete E, Panduro A. Low prevalence of anti-hepatitis C virus antibodies in Mexico: A systematic review. Intervirology 2007; 50: 1-8.

  11. Anonimous. Morbilidad y mortalidad por cirrosis hepática. In: Salud: México 2006. México, D.F.: Secretaría Salud; 2007.

  12. Anonimous. Programa Nacional de Salud 2007-2012. México, D.F., México: Secretaría de Salud; 2007.

  13. Burguete-García AI, Conde-González CJ, Jimenez-Mendez R, Juarez-Diaz Y, Meda-Monzon E, Torres-Poveda K, Madrid- Marina V. Hepatitis C seroprevalence and correlation between viral load and viral genotype among primary care clients in Mexico. Sal Pub Mex 2011; 53(Suppl. 1): S7-S12.

  14. Romero-Figueroa S, Ceballos-Salgado E, Santillan-Arreygue L, Miranda-Garcia M, Rubio-Lezama M, Garduno-Garcia JJ. Risk factors associated with hepatitis C virus infection in an urban population of the State of Mexico. Archives of Virology 2012; 157: 329-32.

  15. Campollo O, Roman S, Panduro A, Hernandez G, Diaz-Barriga L, Balanzario MC, Cunningham JK. Non-injection drug use and hepatitis C among drug treatment clients in west central Mexico. Drug Alcohol Depend 2012; 123: 269-72.

  16. Mendez-Sanchez N, Motola-Kuba D, Chavez-Tapia NC, Bahena J, Correa-Rotter R, Uribe M. Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary- care hospital in Mexico City, Mexico. J Clin Microbiol 2004; 42: 4321-2.

  17. White EF, Garfein RS, Brouwer KC, Lozada R, Ramos R, Firestone-Cruz M, Perez SG, et al. Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. Sal Pub Mex 2007; 49: 165-72.

  18. Dehesa-Violante M, Bosques-Padilla F, Kershenobich-Stalnikowitz D. Prevalence of hepatitis C virus genotypes in Mexican patients. Rev Gastroenterol Mex 2007; 72: 344-8. López-Colombo A, et al. , 2014; 13 (6): 746-752 752

  19. Garcia-Montalvo BM, Macossay-Castillo M. Preliminary data for genotype distribution and epidemiological aspects of hepatitis C virus infection in blood donors from Yucatan, Mexico. Transfusion Medicine 2007; 17: 488-90.

  20. Rivas-Estilla AM, Cordero-Perez P, Trujillo-Murillo Kdel C, Ramos-Jimenez J, Chen-Lopez C, Garza-Rodriguez Mde L, Ramirez-Gutierrez A, et al. Genotyping of hepatitis C virus (HCV) in infected patients from Northeast Mexico. Ann Hepatol 2008; 7: 144-7.

  21. Idrovo AJ, Fernandez JA. Which is the real genotype distribution of hepatitis C virus infection in Mexico? Ann Hepatol 2008; 7: 389.

  22. Garcia-Montalvo BM, Galguera-Colorado PL. Distribution of hepatitis C virus genotypes, risk factors and liver disease in patients from Yucatan, Mexico. Ann Hepatol 2008; 7: 345-9.

  23. Mendez-Sanchez N, Gutierrez-Grobe Y, Kobashi-Margain RA. Epidemiology of HCV infection in Latin America. Ann Hepatol 2010; 9(Suppl.): 27-9.

  24. Jimenez-Mendez R, Uribe-Salas F, Lopez-Guillen P, Cisneros- Garza L, Castaneda-Hernandez G. Distribution of HCV genotypes and HCV RNA viral load in different regions of Mexico. Ann Hepatol 2010; 9: 33-9.

  25. Dehesa-Violante M, Nunez-Nateras R. Epidemiology of hepatitis virus B and C. Arch Med Res 2007; 38: 606-11.

  26. Oliveira-Filho AB, Pimenta Ado S, Rojas Mde F, Chagas MC, Crespo DM, Crescente JA, Lemos JA. Likely transmission of hepatitis C virus through sharing of cutting and perforating instruments in blood donors in the State of Para, Northern Brazil. Cad Saude Publica 2010; 26: 837-44.




2020     |     www.medigraphic.com